Reaction
Body Tinea reporting signals
As of the last recalculation, Body Tinea appears in 557 FAERS reports alongside 23 co-occurring drug terms. The strongest observed disproportionality signal is CIMETIDINE (PRR 241.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Cimetidine | 56 | 241.5 | 242.9 |
| Acetylcysteine | 44 | 189.3 | 190.2 |
| Memantine | 56 | 169.9 | 170.6 |
| Memantine Hydrochloride | 56 | 169.9 | 170.6 |
| Anakinra | 58 | 145.7 | 146.2 |
| Lithium Carbonate | 52 | 126.1 | 126.5 |
| Diltiazem Hydrochloride Extended-Release Tablets | 33 | 115.1 | 115.5 |
| Bumetanide | 55 | 86.2 | 86.4 |
| Amitriptyline Hydrochloride | 36 | 81.9 | 82.1 |
| Terbinafine Hydrochloride | 16 | 69.3 | 69.4 |
| Clonidine | 55 | 44.4 | 44.5 |
| Ketoconazole | 19 | 42.4 | 42.5 |
| Lidocaine Hydrochloride | 60 | 41.6 | 41.6 |
| Diltiazem Hydrochloride | 36 | 41.5 | 41.5 |
| Ketoconazole Foam | 13 | 33.6 | 33.7 |
| Ketoconazole Cream, 2% | 13 | 33.5 | 33.5 |
| Montelukast | 62 | 30.9 | 31.0 |
| Hydroxychloroquine Sulfate | 59 | 26.9 | 27.0 |
| Metoroprolol Tartrate | 41 | 25.0 | 25.0 |
| Misoprostol | 6 | 23.3 | 23.3 |
| Apremilast | 59 | 16.7 | 16.7 |
| Encorafenib | 3 | 11.4 | 11.4 |
| Bimekizumab | 6 | 10.6 | 10.6 |